The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial.
 
Gregory P. Botta
Honoraria - Natera
Consulting or Advisory Role - Natera
Speakers' Bureau - Natera
 
Ronan Joseph Kelly
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sanyo; Eisai; EMD Serono; Grail; Ipsen; Lilly; McKesson; Medscape; Merck; Novartis; Novocure; Onc Live; Peerview; Philips Healthcare; Pieris Pharmaceuticals; STERIS; Takeda; Toray Industries
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
Expert Testimony - Merck
 
Zhaohui Jin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); QED Therapeutics (Inst)
 
Hong Ma
Employment - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - Apexigen; AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; I-Mab; Jazz Pharmaceuticals; Merck Sharp & Dohme; Pieris Pharmaceuticals
Research Funding - Adaptimmune (Inst); Arog (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CARsgen Therapeutics (Inst); Daiichi Sankyo (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Oncolys BioPharma (Inst); Pieris Pharmaceuticals (Inst); Triumvira Immunologics, Inc (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; ImaBiotech; Merck Sharp & Dohme; Pieris Pharmaceuticals
 
Dan Zhao
No Relationships to Disclose
 
Rutika Mehta
Honoraria - ASCO; Bristol-Myers Squibb
Consulting or Advisory Role - ASCO; Astellas Pharma; AVEO (I); BostonGene; Bristol-Myers Squibb; Bristol-Myers Squibb (I); EMD Serono (I); Guardant Health; Immunomedics (I); Lilly; Merck; natera; NCCN/Pfizer (I); Novartis; Seagen; Seagen (I)
Speakers' Bureau - Daiichi Sankyo; Gilead Sciences (I); Natera
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Julia C. Carnevale
No Relationships to Disclose
 
Gloria Sierra
Employment - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
JIE JIA
Employment - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
Raffaele Baffa
Employment - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
Zhonghai Li
Employment - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
Dae Won Kim
Honoraria - AstraZeneca
Research Funding - Bold Therapeutics
 
Harry H. Yoon
Consulting or Advisory Role - ALX ONCOLOGY; Amgen (Inst); Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; AstraZeneca; AstraZeneca (Inst); beigene; BeiGene (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology; LSK Biopharma (Inst); Macrogenics (Inst); Merck (Inst); Merck (Inst); Novartis; Novartis (Inst); OncXerna Therapeutics; Zymeworks (Inst)
Research Funding - BeiGene (Inst); Boston Biomedical (Inst); Bristol Myers Squibb Foundation (Inst); CARsgen Therapeutics (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - beigene